Kay AH, et al. - Researchers undertook this retrospective cohort analysis to investigate how an ERAS pathway could influence post-discharge narcotic use for patients with ovarian cancer undergoing open surgery. This study included women who had open ovarian cancer surgeries in 2014 before ERAS (“pre-ERAS”) and in 2016/2018 after ERAS was established (“ERAS”). Patients taking chronic narcotics were eliminated. Overall, 42 pre-ERAS and 94 ERAS patients were analyzed. A shorter hospital stay, less narcotic use in the 24 h before discharge, and filling prescriptions at the time of discharge for less narcotic, were reported in ERAS patients. Fewer additional prescriptions were filled by ERAS patients following hospital discharge. Overall, a reduction in the narcotic requirements of patients in the three months following ovarian cancer surgery seemed to result from an ERAS protocol institution.